Concepedia

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles

Ensieh Sh. Tehraninejad, Elham Azimi Nekoo, Zahra Ezabadi, Batool Hossein Rashidi, Elham Amirchaghmaghi, Elham Pour Matroud

Archives of Medical Science · 2010 · 21 citations · 12 references

DOIFull text

Open access

Abstract

A half-dose, long-acting GnRH agonist can be successfully used in ovarian stimulation and produces a higher number of MII oocytes and embryos. The pregnancy rates with this method are acceptable.

References

12

Selection criteria for human embryo transfer: A comparison of pyruvate uptake and morphology

J. Conaghan, Kate Hardy, Alan H. Handyside et al. · Journal of Assisted Reproduction and Genetics · 1993 · 174 citations

, , +14

Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study*

Luca Dal Prato, Andrea Borini, Giovanni Coticchio et al. · Human Reproduction · 2004 · 50 citations · Full text

Pituitary-ovarian suppression by the standard and half-doses of D-Trp-6-luteinizing hormone-releasing hormone depot

Juan Balasch, Fernando Gómez, Roser Casamitjana et al. · Human Reproduction · 1992 · 36 citations

Endocrinology: Pituitary down-regulation prior to in-vitro fertilization and embryo transfer: a comparison between a single dose of Zoladex depot and multiple daily doses of Suprefact*

Olufunso A. Oyesanya, S. K. Teo, Elaine Phaik Ling Quah et al. · Human Reproduction · 1995 · 32 citations

, , +24

Endocrinology: Subcutaneous goserelin versus intranasal buserelin for pituitary down-regulation in patients undergoing IVF: a randomized comparative study

Juha S. Tapanainen, Outi Hovatta, Kaisa Juntunen et al. · Human Reproduction · 1993 · 31 citations